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Effects of Body Composition, Leptin, and Adiponectin on Bone 
Mineral Density in Prepubertal Girls
Body weight is positively associated with bone mineral density but the relationship 
between obesity and bone mineral density is unclear. Leptin and adiponectin are potential 
independent contributors to bone mineral density. We assessed the correlations of body 
composition, leptin and adiponectin with bone mineral density, and whether leptin, 
adiponectin and body composition determine bone mineral density independently in 
prepubertal girls. Forty-eight prepubertal girls were classified into obese and control groups 
by body mass index. Serum leptin and adiponectin levels were determined by enzyme 
immunoassay. Bone mineral density was measured using dual energy radiography 
absorptiometry and body composition was measured using bioelectrical impedance 
analysis. Lean and fat mass, and leptin were positively correlated with bone mineral density. 
Lean mass was a positive independent predictor of femoral and L-spine bone mineral 
density. Serum leptin was a postivie independent predictor of femoral bone mineral density. 
Fat mass was a negative independent predictor of femoral bone mineral density. In 
prepubertal girls, lean mass has a favorable effect on bone mineral density. Fat mass seems 
not to protect the bone structure against osteoporosis, despite increased mechanical 
loading. Serum leptin may play a biological role in regulating bone metabolism.
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INTRODUCTION
Childhood obesity has become a major public health concern. 
Obesity is a known risk factor for cardiovascular disease, diabe-
tes, hypertension, and cancer (1, 2). However, the relationship 
between obesity and bone mineral density (BMD) is unclear (3). 
 Childhood and adolescence are crucial periods for maximum 
bone mass acquisition, which is associated with genetic poten-
tial, nutritional factors, physical activity, and body composition 
(4). Osteoporosis-related fracture risk is highly dependent on 
BMD (5). Body weight is positively associated with BMD (6) and 
negatively associated with fracture incidence (7). However, it 
remains controversial whether it is lean mass or adipose tissue 
that mediates the bone stimulatory effect exerted by weight (8, 
9). Recent reports indicated that in young female populations, 
lean mass is a positive predictor of BMD, whereas adipose tissue 
is a weaker positive (10) or negative predictor of BMD (11-13). 
Adipose tissue secretes a variety of proteins called adipokines 
into circulation which play important roles in the modulation 
of biological functions. The relationship between adipose tissue 
and BMD is credited not only to stress from mechanical loading 
but also to the metabolic effect of adipokines (14). Leptin and 
adiponectin are potential contributors to BMD. Leptin is a sati-
ety regulating hormone and has a central role not only in regu-
lating energy expenditure, but also in bone metabolism (3), and 
increases the proliferation and differentiation of osteoblasts in 
adults (15). Adiponectin increases insulin sensitivity and may 
improve lipid profiles (16). It has been suggested that high adi-
ponectin levels may cause increased osteoclastic activity and 
low BMD (17). Adiponectin, however, has also been reported to 
increase osteoblastic activity and decrease osteoclastic activity 
in animals (18). 
 The relationship between body composition, especially adi-
pose tissue, and BMD in obese children is clinically important 
because any therapeutic interventions for obesity that modify 
body composition may affect BMD and therefore the risk of os-
teoporosis in later life. Few studies have attempted to investigate 
the effect of body composition and adipokines on BMD in chil-
dren. Accordingly, we investigated the relationship between 
body composition, leptin, adiponectin, and BMD, and whether 
adipokines and body composition determine BMD indepen-
dently in prepubertal girls. 
MATERIALS AND METHODS
This study was approved by the Institutional Review Board of 
Korea University Ansan Hospital (IRB number AS0768). Written 
informed consent was obtained from both subjects and parents. 
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The children who participated in this study were recruited from 
prepubertal girls who visited the outpatient Pediatric Obesity 
Clinic of Department of Pediatrics, Korea University Ansan Hos-
pital, Ansan, Korea. Pubertal stage was determined by a single 
pediatric endocrinologist according to the Tanner scale, and 
subjects who showed pubertal development were excluded. 
None of the participants in this study had a medical history of 
cardiovascular disease, diabetes, hypertension, and other en-
docrine disorders. 
 Height was measured to the nearest 0.1 cm using a rigid stadi-
ometer. Weight was measured to the nearest 0.1 kg using a cali-
brated balance scale. Body mass index (BMI) was calculated as 
the weight in kilograms divided by the square of height in me-
ters. Obese subjects were defined as having a BMI greater than 
or equal to the 95th percentile for their age and sex according to 
2007 Korean national growth chart. Control subjects were de-
fined as having a BMI greater than or equal to the 25th percen-
tile but less than the 75th percentile. Body composition mea-
surements were performed by bioelectrical impedance analy-
sis, using an InBody 4.0 body composition analyzer (Biospace, 
Seoul, Korea). Fat and lean mass were expressed in kilograms.
 BMD was measured by a single technician using dual energy 
radiography absorptiometry (DXA), using Expert version 1.90 
(Lunar Corp., Madison, WI, USA). BMD of the L2-L4 lumbar 
spine and femoral neck was evaluated and expressed in grams/
centimeter2.
 Blood sampling was performed after an overnight fast. Serum 
parathyroid hormone (PTH), osteocalcin, insulin, glucose, total 
cholesterol, triglyceride, LDL-cholesterol, HDL-cholesterol, 
leptin, and adiponectin were measured. Leptin and adiponec-
tin levels were measured with enzyme immunoassay kits (ALP-
CO Diagnostics, Salem, NH, USA and AdipoGen, Inc., Seoul, 
Korea, respectively). Insulin resistance was estimated using a 
homeostatic model assessment of insulin resistance (HOMA-
IR), with the following calculations: HOMA-IR=(insulin [mU/
L]×glucose [mM/L])/22.5.
 Data are expressed as mean ± standard deviation. Anthropo-
metric characteristics, metabolic and biochemical parameters, 
body composition and BMD between obese and control groups 
were compared using an independent t-test. Pearson’s correla-
tion coefficients were calculated to evaluate the relationship 
between BMD and metabolic parameters and body composi-
tion. Multiple linear regression analysis was performed to inves-
tigate whether BMI, serum fasting insulin, leptin, adiponectin 
and body composition determine BMD independently. SPSS 
16.0 software was used for statistical analysis. P values <0.05 
were considered statistically significant. 
RESULTS
Among 48 prepubertal girls who participated in this study, twen-
ty-nine girls were classified into obese group and 19 girls were 
placed into control group. Anthropometric characteristics, met-
abolic and biochemical parameters, body composition and fem-
oral and L-spine BMD of obese and control groups are shown in 
Table 1. Obese group had significantly higher weight, BMI, leptin, 
fat mass and femoral and L-spine BMD compared to control 
group. There were no significant differences in age, height, PTH, 
osteocalcin, lipid profiles, fasting glucose, insulin, HOMA-IR, 
adiponectin and lean mass between obese and control groups.
 The results of Pearson’s correlation of age, height, weight, BMI, 
fat and lean mass, serum leptin, adiponectin and insulin levels, 
with femoral and L-spine BMD are shown in Table 2. Body weight, 
BMI, fat and lean mass, and leptin level were positively corre-
Table 1. Anthropometric characteristics, metabolic and biochemical parameters, 
body composition and bone mineral density of obese and control groups 
Variables Obese (n=29) Control (n=19) P  value
Age (yr) 8.3±1.2 8.8±1.3 0.163
Height (cm) 132.9±8.9 133.7±11.0 0.774
Weight (kg) 38.5±7.9 30.7±7.8 0.002
BMI (kg/m2) 21.62±2.49 16.85±1.56 <0.001
PTH (pg/mL) 26.79±17.69 34.80±8.06 0.545
Osteocalcin (ng/mL) 69.34±19.42 67.51±4.00 0.898
Total cholesterol (mg/dL) 174.8±22.9 171.7±29.0 0.692
Triglyceride (mg/dL) 85.7±44.0 105.2±70.9 0.248
HDL-cholesterol (mg/dL) 52.8±8.2 58.9±16.2 0.146
LDL-cholesterol (mg/dL) 101.8±20.3 91.0±18.7 0.075
Fasting insulin (mIU/L) 14.72±4.88 8.20±1.41 0.076
Fasting glucose (mM/L) 4.94±0.28 5.06±0.33 0.213
HOMA-IR 3.23±1.16 1.84±0.16 0.111
Leptin (ng/mL) 13.18±7.45 6.43±5.41 0.001
Adiponectin (ng/mL) 10.16±2.23 11.56±2.73 0.058
Fat mass (kg) 12.5±4.2 6.8±2.7 <0.001
Lean mass (kg) 24.0±4.1 19.1±0.6 0.108
BMDfemur (g/cm2) 0.791±0.101 0.643±0.096 <0.001
BMDL-spine (g/cm2) 0.763±0.087 0.677±0.081 0.006
Data are shown as mean±standard deviation. 
BMI, body mass index; PTH, parathyroid hormone; HOMA-IR, homeostatic model 
assessment of insulin resistance; BMDfemur, femoral bone mineral density; BMDL-spine; 
L-spine bone mineral density. 
Table 2. Correlation of metabolic parameters and body composition with bone mineral 
density
Variables
BMDfemur BMDL-spine
r P  value r P  value
Age  0.126 0.450 0.213 0.198
Height  0.270 0.101 0.407 0.011
Body weight  0.751 <0.001 0.762 <0.001
BMI  0.797 <0.001 0.709 <0.001
Fat mass  0.750 <0.001 0.681 <0.001
Lean mass  0.818 <0.001 0.830 <0.001
Fasting insulin  0.452 0.021 0.368 0.065
Leptin  0.659 <0.001 0.481 0.003
Adiponectin -0.181 0.277 -0.006 0.974
Coefficients (r) and P  values are calculated using Pearson’s correlation analysis. 
BMI, body mass index; BMDfemur, femoral bone mineral density; BMDL-spine, L-spine bone 
mineral density.
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lated with femoral and L-spine BMD. Fasting insulin had posi-
tive correlations with femoral BMD but not with L-spine BMD. 
Height had positive correlations with L-spine BMD but not with 
femoral BMD. Age and serum adiponectin level were not cor-
related with femoral and L-spine BMD. 
 The results of multiple linear regression analysis to investigate 
whether BMI, leptin, adiponectin, fasting insulin and body com-
position determine BMD independently are shown in Table 3. 
Lean mass was found to be a positive independent predictor of 
femoral and L-spine BMD. Serum leptin was found to be a pos-
itive independent predictor of femoral BMD, but not of L-spine 
BMD. Fat mass was found to be a negative independent predic-
tor of femoral BMD, but not of L-spine BMD. BMI, serum adi-
ponectin and fasting insulin levels were not independent pre-
dictors of BMD.
 
DISCUSSION
The results of this study agree with previous studies that docu-
mented a positive relationship between body weight and BMD 
(6). The BMD of obese children is influenced by body weight as 
excessive weight produces a mechanical force on the bones, 
thereby stimulating osteogenesis (19). 
 Obesity is characterized by increased body weight with excess 
body fat and a relative increase of lean mass. It has been debat-
ed which of lean mass or fat mass has more influence on bone 
stimulatory effect (8, 20). Previous studies indicated that regard-
less of age or gender, lean mass has a strong positive influence 
on BMD (10). However, the results of previous studies on the 
relation between fat mass and BMD were conflicting. Adipose 
tissue can be a weaker positive predictor (10) or stronger predic-
tor (6) than lean mass, or even a negative predictor of BMD (13).
 Our results indicate that despite its positive correlation with 
femoral L-spine BMD, fat mass is a negative independent pre-
dictor of femoral BMD. This finding is consistent with previous 
reports suggesting that bone strength is primarily determined 
by dynamic loads from muscle force, not static loads such as fat 
mass (21). The mechanism for the negative effect of fat mass on 
bone mass, as observed in this study, is unknown.
 Adipose tissue is no longer viewed as a metabolically passive 
fuel depot for energy substrate. Rather, it is a metabolically active 
tissue, secreting a variety of adipokines that modulate biologi-
cal functions. It is suggested that some adipokines participate 
in bone metabolism. Leptin and adiponectin are potential con-
tributors to BMD.
 Leptin has been proposed to be a mediator of adipose tissue 
hormonal effect on bone mass (3). The role of leptin in bone 
metabolism is not fully understood, but in animal studies, leptin 
deficient mice have demonstrated a ‘high bone mass phenotype’ 
(22). Some human studies have failed to show any association 
between serum leptin levels and BMD (3, 23), whereas others 
have reported a positive association between leptin and BMD 
(24). In a few recent studies, leptin was negatively correlated 
with BMD (25). We found that serum leptin levels were posi-
tively correlated with both femoral and L-spine BMD, and that 
leptin was an independent positive predictor of femoral BMD 
in prepubertal girls. 
 Adiponectin acts directly on bone to induce human osteoblast 
proliferation and differentiation, and to increase osteoclast forma-
tion indirectly (17, 26). A previous study showed that adiponec-
tin exerted a negative independent effect on BMD (27). Some 
studies also reported that there was no independent relation-
ship between adiponectin and BMD (28, 29). We did not find 
any correlations between adiponectin and BMD. 
 Another link between obesity and BMD is insulin. Insulin re-
duces hepatic synthesis of sex hormone carriers, and leads to an 
increase in free form sex hormones, which stimulates the activ-
ity of osteoblasts (30). We found a weak positive correlation be-
tween fasting insulin and femoral BMD, but no significant cor-
relation between fasting insulin and L-spine BMD.
 We limited our study sample to prepubertal girls to control 
for other factors that affect BMD. In puberty, growth hormones 
and sex steroids actively participate in the development of bone 
structure as a result of normal growth (4). Sex seems to be an 
important determinant of BMD, probably because of different 
muscle and sex steroid levels in boy and girls.
 It should be noted that the cross sectional nature of this study 
limits the interpretation of our results, especially with regard to 
cause-effect interactions. Another limitation is the fact that other 
data about the life style of participants, such as calcium intake 
and exercise, were not evaluated.
 In conclusion, in prepubertal girls, lean mass has a favorable 
effect on BMD. Fat mass seems not to protect the bone struc-
ture against osteoporosis, despite increased mechanical load-
ing. Serum leptin may play a biological role in regulating bone 
metabolism. Further prospective studies including male and 
pubertal participants are necessary to apply our findings to the 
general population.
Table 3. Body mass index, serum fasting insulin, leptin, adiponectin levels and body 
composition as independent predictors of bone mineral density
Variables
BMDfemur BMDL-spine
β P  value β P  value
BMI 0.009 0.399 0.016 0.175
Fasting insulin 0.001 0.597 0.001 0.829
Leptin 0.007 0.012 0.000 0.899
Adiponectin 0.000 0.972 0.005 0.392
Fat mass -0.016 0.049 -0.010 0.233
Lean mass 0.022 <0.001 0.019 0.001
Results of multiple linear regression analyses including BMI, serum fasting insulin, 
leptin, adiponectin levels, fat and lean mass on bone mineral density. Unstandardized 
coefficients (β) and P  values are presented.
BMDfemur, femoral bone mineral density; BMDL-spine, L-spine bone mineral density; BMI, 
body mass index.
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